As WuXi talks of a surge in its outsourced manufacturing services, the company has begun offering high-potency active pharmaceutical ingredients (HPAPIs).
Outsourcing-Pharma presents its latest round of movements in the pharma outsourcing sector, including appointments at WuXi PharmaTech, Sundia, CMC Biologics and Xoma.
Johnson & Johnson has tapped Chinese WuXi PharmaTech for additional R&D services, following the trend towards high-level, strategic collaborations between drugmakers and contract research organisations.
China's Wuxi PharmaTech saw revenues race away across its divisions
in the first quarter of 2008, benefitting from the continued shift
towards outsourcing of manufacturing and laboratory functions by
the pharmaceutical industry.
Shanghai-based biotech company WuXi PharmaTech has grown more than
100 times in the last 5 years after operating successfully in
China's infant biotech industry by providing variety of outsourcing
services in drug R&D.